Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment
- Status
- TERMINATED
- Phase
- PHASE2
Collection of Transplant Stem Cells for Plasma Cell Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
1068GCC Evaluate Efficacy & Explore Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy (BIPN) in Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Velcade (Bortezomib) Consolidation After Transplant
- Status
- COMPLETED
- Phase
- PHASE3
Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
CP-751,871 Treatment For Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years
- Status
- UNKNOWN
- Phase
- PHASE3
Lenalidomide and Low Dose Dexamethasone Versus Bortezomib, Lenalidomide and Low Dose Dexamethasone for Induction, in Patients With Previously Untreated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM
- Status
- COMPLETED
- Phase
- PHASE2
Retrospective Survey of Re-treatment With Bortezomib
- Status
- COMPLETED
- Phase
- N/A
Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib Consolidation Trial
- Status
- COMPLETED
- Phase
- PHASE2
Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Phase I Study of CS-7017 and Bexarotene
- Status
- TERMINATED
- Phase
- PHASE1
Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2